Krystal Biotech Inc reports results for the quarter ended in June - Earnings Summary

Krystal Biotech

05/08/2024 14:31

* Krystal Biotech Inc  KRYS.OQ  reported quarterly adjusted
earnings of 53 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-1.25.  The mean expectation of eight analysts
for the quarter was for earnings of 58 cents per share. Wall
Street expected results to range from 37 cents to 96 cents per
share.
    * Revenue was $70.28 million​; analysts expected $65.34
million. 
    * Krystal Biotech Inc's reported EPS for the quarter was 53
cents​.
    * The company reported quarterly net income of $15.57
million.
    * Krystal Biotech Inc shares had risen by 4.5% this
quarter and
gained 54.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Krystal Biotech
Inc is $195.00 
This summary was machine generated from LSEG data August 5 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.58           0.53           Missed
 Mar. 31 2024      0.15           0.03           Missed
 Dec. 31 2023      -0.42          0.30           Beat
 Sep. 30 2023      -0.29          -0.69          Missed